We are very pleased with the reliability and performance of this complex respiratory panel. The simultaneous detection of COVID-19, Flu A, Flu B and RSV during Flu season would help further augment the BD MAX™ testing capacity by over 50,000 tests per week.
BioGX COVID-19, Flu A, Flu B, RSV – RT-PCR for BD MAX™ System
The test is offered in BioGX’s trusted, easy to use Sample-Ready™ format where all required reagents for real-time PCR are lyophilized in a single tube. BioGX provided tube snaps into a test-specific position on the BD MAX™ total nucleic acid extraction cartridge enabling Sample-to-Answer molecular testing. BioGX kits can be shipped anywhere in the world with no refrigeration required.
The BioGX multiplex COVID-19, Flu A, Flu B and RSV test is intended for qualitative detection of RNA specific to SARS-CoV-2, Influenza A, Influenza B, and Respiratory Syncytial Virus A/B that may be present in Pharyngeal and Nasopharyngeal swab collections in transport media and saline, obtained from individuals at risk of respiratory viral infections.
The assay is provided in a BioGX proprietary Sample-Ready™ lyophilized format sealed in a BD MAX™ tube. Each tube contains all PCR components such as primers, probes, enzymes, dNTPs, and buffers required for real-time PCR-based testing of one sample.
For more information about this product email email@example.com.
The BD MAX™ System is a fully integrated and automated molecular diagnostic platform already in use at thousands of laboratories worldwide.
- Single lyophilized tube minimizes setup time
- Time-to-result: <2 hours for 24 samples
- Increase hands-free time with the fully automated BD MAX™
- Scalable workflow allows you to run a single sample or batches of up to 24 samples.
- Quality: CE-IVD Marked
- Cost Effective